Header Logo

Connection

John Harris to Immunotherapy

This is a "connection" page, showing publications John Harris has written about Immunotherapy.
Connection Strength

2.126
  1. Riding RL, Richmond JM, Fukuda K, Harris JE. Type I interferon signaling limits viral vector priming of CD8+ T cells during initiation of vitiligo and melanoma immunotherapy. Pigment Cell Melanoma Res. 2021 07; 34(4):683-695.
    View in: PubMed
    Score: 0.597
  2. Riding RL, Harris JE. The Role of Memory CD8+ T Cells in Vitiligo. J Immunol. 2019 07 01; 203(1):11-19.
    View in: PubMed
    Score: 0.545
  3. Richmond JM, Strassner JP, Essien KI, Harris JE. T-cell positioning by chemokines in autoimmune skin diseases. Immunol Rev. 2019 05; 289(1):186-204.
    View in: PubMed
    Score: 0.539
  4. Rork JF, Rashighi M, Harris JE. Understanding autoimmunity of vitiligo and alopecia areata. Curr Opin Pediatr. 2016 08; 28(4):463-9.
    View in: PubMed
    Score: 0.445
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.